Somatotypes trajectories during adulthood and their association with COPD phenotypes

Rationale Chronic obstructive pulmonary disease (COPD) comprises distinct phenotypes, all characterised by airflow limitation. Objectives We hypothesised that somatotype changes – as a surrogate of adiposity – from early adulthood follow different trajectories to reach distinct phenotypes. Methods Using the validated Stunkard's Pictogram, 356 COPD patients chose the somatotype that best reflects their current body build and those at ages 18, 30, 40 and 50 years. An unbiased group-based trajectory modelling was used to determine somatotype trajectories. We then compared the current COPD-related clinical and phenotypic characteristics of subjects belonging to each trajectory. Measurements and main results At 18 years of age, 88% of the participants described having a lean or medium somatotype (estimated body mass index (BMI) between 19 and 23 kg·m−2) while the other 12% a heavier somatotype (estimated BMI between 25 and 27 kg·m−2). From age 18 onwards, five distinct trajectories were observed. Four of them demonstrating a continuous increase in adiposity throughout adulthood with the exception of one, where the initial increase was followed by loss of adiposity after age 40. Patients with this trajectory were primarily females with low BMI and DLCO (diffusing capacity of the lung for carbon monoxide). A persistently lean trajectory was seen in 14% of the cohort. This group had significantly lower forced expiratory volume in 1 s (FEV1), DLCO, more emphysema and a worse BODE (BMI, airflow obstruction, dyspnoea and exercise capacity) score thus resembling the multiple organ loss of tissue (MOLT) phenotype. Conclusions COPD patients have distinct somatotype trajectories throughout adulthood. Those with the MOLT phenotype maintain a lean trajectory throughout life. Smoking subjects with this lean phenotype in early adulthood deserve particular attention as they seem to develop more severe COPD. In smoking-related COPD, somatotype trajectories are associated with the final COPD phenotype. Specifically, the “pink puffer” or multiorgan loss of tissue (MOLT) phenotype occurs where the patient remains lean. https://bit.ly/2YNhwfu

[1]  X. Jouven,et al.  Body Silhouette Trajectories Across the Lifespan and Vascular Aging: The Paris Prospective Study 3 , 2018, Hypertension.

[2]  Valéria Lima Passos,et al.  Group-based multi-trajectory modeling , 2018, Statistical methods in medical research.

[3]  E. Silverman,et al.  Emphysema and extrapulmonary tissue loss in COPD: a multi-organ loss of tissue phenotype , 2018, European Respiratory Journal.

[4]  B. Celli,et al.  COPD: time to improve its taxonomy? , 2018, ERJ Open Research.

[5]  F. Hu,et al.  Associations between genetic variants associated with body mass index and trajectories of body fatness across the life course: a longitudinal analysis. , 2017, International journal of epidemiology.

[6]  J. Manson,et al.  Group-Based Trajectory of Body Shape From Ages 5 to 55 Years and Cardiometabolic Disease Risk in 2 US Cohorts , 2017, American journal of epidemiology.

[7]  M. Decramer,et al.  A simple algorithm for the identification of clinical COPD phenotypes , 2017, European Respiratory Journal.

[8]  B. Celli,et al.  What does endotyping mean for treatment in chronic obstructive pulmonary disease? , 2017, The Lancet.

[9]  Jennifer G. Dy,et al.  Do COPD subtypes really exist? COPD heterogeneity and clustering in 10 independent cohorts , 2017, Thorax.

[10]  F. Martinez Early-Life Origins of Chronic Obstructive Pulmonary Disease. , 2016, The New England journal of medicine.

[11]  W. Willett,et al.  Trajectory of body shape across the lifespan and cancer risk , 2016, International journal of cancer.

[12]  W. Willett,et al.  Trajectory of body shape in early and middle life and all cause and cause specific mortality: results from two prospective US cohort studies , 2016, British Medical Journal.

[13]  B. Celli,et al.  Continuous fat-free mass decline in COPD: fact or fiction? , 2015, European Respiratory Journal.

[14]  J. Soriano,et al.  Lung-Function Trajectories Leading to Chronic Obstructive Pulmonary Disease. , 2015, The New England journal of medicine.

[15]  J. R. Landis,et al.  An index of risk for obstructive airways disease. , 2015, The American review of respiratory disease.

[16]  Courtney Crim,et al.  Identification of five chronic obstructive pulmonary disease subgroups with different prognoses in the ECLIPSE cohort using cluster analysis. , 2015, Annals of the American Thoracic Society.

[17]  B. Celli,et al.  Comorbidity Distribution, Clinical Expression and Survival in COPD Patients with Different Body Mass Index. , 2014, Chronic obstructive pulmonary diseases.

[18]  Stephanie A. Santorico,et al.  Cluster analysis in the COPDGene study identifies subtypes of smokers with distinct patterns of airway disease and emphysema , 2014, Thorax.

[19]  V. Peinado,et al.  Lungs, bone marrow, and adipose tissue. A network approach to the pathobiology of chronic obstructive pulmonary disease. , 2013, American journal of respiratory and critical care medicine.

[20]  R. Casaburi,et al.  Changes in Body Composition in Patients with Chronic Obstructive Pulmonary Disease: Do They Influence Patient-Related Outcomes? , 2013, Annals of Nutrition and Metabolism.

[21]  E. Regan,et al.  Genetic Epidemiology of COPD (COPDGene) Study Design , 2011, COPD.

[22]  Josep Roca,et al.  Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypes , 2010, Thorax.

[23]  Reza Malekzadeh,et al.  Pictogram use was validated for estimating individual's body mass index. , 2010, Journal of clinical epidemiology.

[24]  A. Caplan,et al.  Adult mesenchymal stem cells: an innovative therapeutic for lung diseases. , 2010, Discovery medicine.

[25]  A. Sood Pulmonary Physiology and Pathophysiology in Obesity Obesity , adipokines , and lung disease , 2010 .

[26]  D. Caillaud,et al.  Clinical COPD phenotypes: a novel approach using principal component and cluster analyses , 2010, European Respiratory Journal.

[27]  W. Herman,et al.  Getting Heavier, Younger: Trajectories of Obesity over the Life Course , 2009, International Journal of Obesity.

[28]  Harald Grallert,et al.  Genome Wide Association (GWA) Study for Early Onset Extreme Obesity Supports the Role of Fat Mass and Obesity Associated Gene (FTO) Variants , 2007, PloS one.

[29]  M. Jarvelin,et al.  A Common Variant in the FTO Gene Is Associated with Body Mass Index and Predisposes to Childhood and Adult Obesity , 2007, Science.

[30]  G Laszlo,et al.  Standardisation of lung function testing: helpful guidance from the ATS/ERS Task Force , 2006, Thorax.

[31]  Sun Ha Jee,et al.  Body-mass index and mortality in Korean men and women. , 2006, The New England journal of medicine.

[32]  E. Wouters,et al.  Body composition and mortality in chronic obstructive pulmonary disease. , 2005, The American journal of clinical nutrition.

[33]  Ciro Casanova,et al.  The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. , 2004, The New England journal of medicine.

[34]  J. Fleg,et al.  Body mass index and the risk of COPD. , 2002, Chest.

[35]  E. Wouters,et al.  Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.

[36]  W. Willett,et al.  Remote recall of childhood height, weight, and body build by elderly subjects. , 1993, American journal of epidemiology.

[37]  P. Paré,et al.  The diagnosis of emphysema. A computed tomographic-pathologic correlation. , 1986, The American review of respiratory disease.

[38]  S. Kety,et al.  Genetics of Neurological and Psychiatric Disorders , 1982 .

[39]  R. Eberhart,et al.  Acute respiratory insufficiency. Treatment with prolonged extracorporeal oxygenation. , 1972 .

[40]  A. Leatham,et al.  External electric stimulator for treatment of ventricular standstill. , 1956, Lancet.

[41]  E. Regan,et al.  Genome-wide association analysis of body mass in chronic obstructive pulmonary disease. , 2011, American journal of respiratory cell and molecular biology.

[42]  S. Kira [Respiratory insufficiency]. , 2003, Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society.

[43]  ATS statement: guidelines for the six-minute walk test. , 2002, American journal of respiratory and critical care medicine.

[44]  A. Bankier,et al.  CT quantification of pulmonary emphysema: assessment of lung structure and function. , 2002, Critical reviews in computed tomography.

[45]  ATS Statement , 2002 .

[46]  A R Feinstein,et al.  Directionality and scientific inference. , 1989, Journal of clinical epidemiology.

[47]  A. Stunkard,et al.  Use of the Danish Adoption Register for the study of obesity and thinness. , 1983, Research publications - Association for Research in Nervous and Mental Disease.